FDA Approves MONOFERRIC for Iron Deficiency Anemia

The U.S. Food and Drug Administration (FDA) has approved MONOFERRIC (ferric derisomaltose) for the treatment of iron deficiency anemia in adult patients who are intolerant to oral iron, have had an unsatisfactory response to oral iron, or have non-hemodialysis dependent chronic kidney disease.